EUVIMEDEUVIMED entdecken
Crossref

Feasibility of a targeted protein panel for personalized treatment in advanced adenoid cystic carcinoma: A proof‑of‑concept study

Rubens Thölken, Adrian Von Witzleben, Simon Laban, Stephanie Weissinger, Thomas Hoffmann, Patrick Schuler, Johannes Doescher

Oncology Letters · 06.11.2026 · 33 (1) · 1-8

DOI: 10.3892/ol.2026.15939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 06.11.2026. Verfasst von Rubens Thölken und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Thölken, R., Witzleben, A. V., Laban, S., Weissinger, S., Hoffmann, T., Schuler, P., & Doescher, J. (2026). Feasibility of a targeted protein panel for personalized treatment in advanced adenoid cystic carcinoma: A proof‑of‑concept study. Oncology Letters, 33(1), 1-8. https://doi.org/10.3892/ol.2026.15939

Vancouver

Thölken R, Witzleben AV, Laban S, Weissinger S, Hoffmann T, Schuler P, et al. Feasibility of a targeted protein panel for personalized treatment in advanced adenoid cystic carcinoma: A proof‑of‑concept study. Oncology Letters. 2026;33(1):1-8. doi:10.3892/ol.2026.15939

BibTeX
@article{Thlken2026,
  author = {Thölken, Rubens and Witzleben, Adrian Von and Laban, Simon and Weissinger, Stephanie and Hoffmann, Thomas and Schuler, Patrick and Doescher, Johannes},
  title = {Feasibility of a targeted protein panel for personalized treatment in advanced adenoid cystic carcinoma: A proof‑of‑concept study},
  journal = {Oncology Letters},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {1--8},
  doi = {10.3892/ol.2026.15939}
}
Kostenlos starten →